Latest news
Protecting Older Australians – COVID-19 Update 2 June 2023
Read the Protecting Older Australians COVID-19 update newsletter from 2 June 2023.
ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older
ATAGI has made recommendations on the use of bivalent COVID-19 vaccines as a primary course.
Protecting Older Australians – COVID-19 update 22 May 2023
Read the Protecting Older Australians COVID-19 update newsletter from 22 May 2023.
Protecting Older Australians – COVID-19 update 8 May 2023
In this issue, read about managing COVID-19, COVID-19 vaccination booster doses, influenza vaccinations, accessing COVID-19 PCR testing through Medicare, IPC Lead Nurse training grants, PPE winter deployment, and the ACCPA Winter preparedness webinar.
Protecting Older Australians – COVID-19 update 4 April 2023
In this issue: Letter to aged care providers on COVID-19 preparedness, Infection Control and Prevention (IPC) overview, Provider IPC responsibility, The commission's IPC oversight and IPC training grants available.
Top up your COVID-19 protection
The Australian Government has launched a new advertising campaign to encourage adults to get a COVID-19 booster if it has been 6 months or more since their last COVID-19 vaccination or infection.
Release of the Australian Government's response to the Review of COVID-19 Vaccine and Treatment Purchasing and Procurement
The Australian Government has responded to the Halton review into COVID-19 vaccine and treatment procurement.
ATAGI recommendations on use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.
ATAGI 2023 booster advice
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 boosters in 2023. These recommendations replace previous ATAGI COVID-19 vaccine booster advice.
Protecting Older Australians – COVID-19 newsletter – 30 January 2023
In this issue: COVID-19 vaccination support; Reminder annual reporting for influenza vaccinations in aged care; and Changes to how services request Commonwealth COVID-19 Support , including RAT kits, PCR testing, Oral antiviral treatments, workforce and PPE.
Travellers from China required to undertake COVID-19 testing before travel
The Australian Government will introduce pre-departure testing for COVID-19 for people travelling to Australia from the People’s Republic of China.
New COVID-19 variant leads to increase in cases
A statement from Professor Paul Kelly, Australian Government Chief Medical Officer, on the increase in COVID-19 cases due to a new Omicron variant.
ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on Pfizer booster doses for children aged 5 to 11 years.
Cancer Australia – Yarn for Life
Cancer Australia’s Yarn for Life is the first national cancer awareness campaign developed for and by Aboriginal and Torres Strait Islander people.
Protecting Older Australians – COVID-19 update 14 October 2022
In this edition: Aged care COVID-19 update webinar and COVID-19 isolation requirements for high-risk settings, including residential aged care homes.
ATAGI recommend the COVID-19 vaccination for some children aged 6 months to under 5 years
Australia’s immunisation experts, the Australian Technical Advisory Group on Immunisation, recommend COVID-19 vaccination for some children aged 6 months to under 5 years who have an increased risk of getting very sick from COVID-19. The COVID-19 vaccination will help reduce this risk.
Take a Step
Did you know that in Australia, Aboriginal and Torres Strait Islander people 24 years and under are 3 times more likely than other young people to die by suicide?
ATAGI statement on use of the Moderna bivalent Original/Omicron vaccine
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 Moderna Spikevax Bivalent Original/Omicron BA.1 vaccine.
AHPPC Statement – reduced isolation period for COVID-19 cases
The Australian Health Protection Principal Committee (AHPPC) notes the need for a proportionate approach to isolation for those with COVID‑19 infections at this stage of the pandemic.
ATAGI update following weekly COVID-19 meeting – 31 August 2022
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 31 August 2022.
National Cabinet Statement on COVID-19 settings
The following statement was released following the conclusion of National Cabinet on Wednesday 31 August 2022.
ATAGI update following weekly COVID-19 meeting – 24 August 2022
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 24 August 2022.
Novavax vaccine for adolescents aged 12–17 years
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Novavax vaccine for adolescents aged 12-17 years.
Keep Your Spirit Strong
During COVID-19 many people face challenges that have impacted their mental health. The ‘Keep Your Spirit Strong’ project aims to help Aboriginal and Torres Strait Islanders take important steps to ensure they are prioritising their social and emotional wellbeing.
Last updated: